Innovations & Thérapeutiques en Oncologie

Innovations & Thérapeutiques en Oncologie

The scientific journal of Unicancer, published in partnership with the AERIO and SFjROInnovations & Thérapeutiques en Oncologie has two main missions which are :

  • To bring knowledge about the largest number of innovations in oncology, trying as accurately as possible to define their benefits, but also their restrictions and limitations.

  • To echo the everyday impact of both these innovations and also any new methods in clinical practice, new ways of using them and new areas of interest from specific clinical situations.

With its eyes set resolutely on the future, the six annual editions of this Journal will quickly find their home with all French speaking oncologists.

The Innovations & Thérapeutiques en Oncologie review has an editing committee comprised of successful professionals who are expert in their respective sectors. It can therefore offer you excellent content which will contribute to the development of the future of oncology.


Volume 10, issue 3, May-June 2024


En accès libre IFODS 2024. The French Oncology Meeting
Jean-Philippe Spano, Françoise Mornex
Free Access

Humeur/Opinion Column

Article American universities gone adrift
Jacques Robert

Sélection et décryptage/Comments and Analysis

Article Comments and analysis
Patricia de Cremoux, Jacques Robert

Dossier : Congrès IFODS/IFODS Congress

Article IFODS abstracts

Article Introduction : Onco Startup Summit
Comité d’organisation de l’Onco Startup Summit

See full Table of contents >


See full past issues >

Editorial policy

Here you will find all JLE policies regarding publication in our journals. JLE journals follow the recommendations of the ICMJE (International Committee of Medical Journal Editors). These guidelines are the reference for best practices and ethical standards for the conduct and presentation of research and other information published in medical journals.


Version française de notre politique éditoriale